Friday, June 26, 2026

Fraunhofer Gesellschaft Zur Vs. The Controller General of Patents

Fraunhofer Gesellschaft Zur Vs. The Controller General of Patents:17.06.2026:IPDPTA/11/2024:CalHC: Ravi Krishan Kapur H.J.

The Court considered a dispute concerning the rejection of a patent application for alleged non-compliance with the disclosure requirements under the Patents Act, 1970. The case arose from allegations that the patent specification failed to sufficiently describe the invention, lacked clarity, omitted essential technical details, and did not disclose the source and geographical origin of the biological material used in the invention.

The principal question before the Court was whether the Controller of Patents was justified in rejecting the patent application under Section 15 of the Patents Act for non-compliance with Section 10 of the Act.

After examining the material on record and the submissions of the parties, court observed that a patent applicant must make a complete, clear and enabling disclosure so that a person skilled in the art can perform the invention without undue experimentation.

The Court held that the appellant's specification failed to satisfy the mandatory requirements of Sections 10(4) and 10(5) of the Patents Act, emphasizing that omission to disclose the source and geographical origin of biological material and failure to provide sufficient technical disclosure are fatal defects in a patent specification.

Accordingly, the Court dismissed the appeal and upheld the Controller's order rejecting the patent application.

Disclaimer: Readers are advised not to treat this as a substitute for legal advice as it is based on limited information and is intended solely for general informational purposes.

Comprehensive Analytical Article

Insufficiency of Disclosure in Patent Specification and Rejection of Patent Appeal

Introduction

The judgment delivered by the Intellectual Property Rights Division of the High Court at Calcutta is an important addition to Indian patent jurisprudence on the fundamental requirement of sufficiency of disclosure. The decision reiterates that the grant of a patent is a statutory monopoly available only in exchange for complete and meaningful disclosure of the invention to the public. The Court reaffirmed that vague descriptions, broad claim language, absence of workable examples and failure to disclose the source and geographical origin of biological material can justify refusal of patent protection.

The judgment is particularly significant for patent applicants, biotechnology companies, pharmaceutical innovators, research institutions and intellectual property professionals. It reinforces that patent specifications must not merely describe the desired result but must enable a person skilled in the relevant field to actually perform the invention. The decision also highlights India's commitment to preventing biopiracy by insisting upon compliance with statutory requirements relating to biological material.

Factual and Procedural Background

The appellant, Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschunge, filed Patent Application No. 202137013369 relating to an invention titled "Method for Stimulating the Growth of Biomass in a Liquid Inside a Bioreactor." The application was filed on 26 March 2021 and was subsequently examined by the Patent Office after a request for examination was submitted.

During examination, the Patent Office issued a First Examination Report pointing out that the complete specification did not comply with Section 10 of the Patents Act, 1970. According to the Patent Office, the specification lacked clarity, proper structure and sufficient disclosure. The applicant submitted amendments in response to the examination report in an attempt to overcome the objections.

Despite these amendments, the Controller of Patents remained unconvinced. A hearing notice was issued raising concerns regarding insufficiency of disclosure, lack of clarity, broad and indefinite claims and non-compliance with the statutory requirements governing patent specifications. Eventually, by an order dated 24 May 2024, the Controller rejected the application under Section 15 of the Patents Act.

Aggrieved by this rejection, the appellant preferred an appeal before the Intellectual Property Rights Division of the High Court at Calcutta. The appellant argued that the Controller had introduced fresh objections during the hearing without conducting a fresh examination and had incorrectly concluded that the specification failed to satisfy the statutory requirements. The appellant also contended that disclosure of the geographical origin of biological material was unnecessary because the invention did not claim the biological material itself.

The respondents defended the rejection by contending that the patent specification was fundamentally deficient. According to the respondents, it lacked sufficient technical disclosure, working examples, experimental parameters and necessary information regarding the biological material used in the invention. They also argued that the amended claims remained vague and incapable of enabling a skilled person to reproduce the invention without excessive experimentation.

Dispute Before the Court

The principal controversy before the Court was whether the Controller of Patents had correctly rejected the patent application for failing to comply with the mandatory disclosure requirements contained in Section 10 of the Patents Act, 1970.

The Court was also required to determine whether the specification adequately disclosed the invention, whether the absence of working examples and technical parameters rendered the claims insufficient, whether disclosure of the source and geographical origin of biological material was mandatory in the facts of the case, and whether the Controller had violated procedural safeguards by allegedly introducing new objections at the hearing stage.

The appellant maintained that the invention was sufficiently disclosed and capable of being worked by a person skilled in the relevant field without undue experimentation. It also argued that the Controller had misunderstood the specification and had taken isolated expressions out of context while assessing clarity.

The respondents, on the other hand, contended that the specification merely described desired outcomes without providing the technical information necessary for implementation. According to them, the omission of biological source information and the absence of enabling disclosure rendered the application fundamentally defective and incapable of receiving patent protection.

Reasoning and Analysis of the Court

The Court undertook a detailed examination of Section 10 of the Patents Act, 1970, which prescribes the mandatory contents of a complete specification. It observed that every patent specification must fully and particularly describe the invention, explain its operation or use, disclose the best method known to the applicant for performing the invention, and conclude with claims that are clear, succinct and fairly based on the disclosure. These statutory requirements are not procedural formalities but constitute the foundation upon which the grant of a patent rests.

The Court emphasized that the doctrine of sufficiency of disclosure is one of the cornerstones of patent law. A patent grants the inventor a statutory monopoly, but such monopoly is justified only because the inventor, in return, contributes meaningful technical knowledge to the public. Consequently, the complete specification must enable a person ordinarily skilled in the relevant technical field to perform the invention without having to undertake further inventive work or excessive experimentation. Mere statements of desired results or broad theoretical concepts cannot satisfy this legal standard.

Applying these principles, the Court found significant deficiencies in the appellant's specification. Although the invention related to stimulating biomass growth in a bioreactor through irradiation, the specification failed to disclose essential operational parameters. It contained wide ranges of irradiation levels and time intervals without explaining how those parameters were to be selected or implemented in practice. Expressions such as "periodically", "at most", "maximum of", and "time interval" were considered too vague because they failed to define workable technical limits. The absence of experimental data, practical examples, or reproducible methodology meant that a skilled person would have to engage in extensive trial and error before successfully carrying out the invention. Such a disclosure, the Court held, fell short of the statutory requirement under Sections 10(4)(a), 10(4)(b), and 10(5) of the Patents Act.

Another significant aspect of the judgment concerned the disclosure of biological material. The appellant argued that disclosure of the source and geographical origin of biological material was unnecessary because the invention did not claim ownership over the biological material itself. The Court rejected this submission. It held that whenever biological material is used in an invention, the second proviso to Section 10(4)(d) expressly requires disclosure of its source and geographical origin. This requirement exists irrespective of whether the biological material itself is claimed as the invention. The statutory mandate serves important public policy objectives, including prevention of biopiracy, protection of India's biological resources, and compliance with the Biological Diversity Act, 2002 and the Convention on Biological Diversity. Consequently, failure to disclose the source and geographical origin of the microorganisms used in the invention constituted a serious defect that independently justified rejection of the application.

The Court also referred to the Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, particularly paragraphs 11.1 and 11.2, which reiterate that complete specifications involving biological material must contain sufficient disclosure and, where necessary, details of deposits under the Budapest Treaty together with the source and geographical origin of the biological material. The Court observed that although these Guidelines do not override the statute, they faithfully reflect the legislative requirements contained in Section 10 and therefore support a strict approach towards compliance.

While interpreting Section 10, the Court relied upon and discussed several judicial precedents. It referred to Farbwerke Hoechst A.G. v. Unichem Laboratories, AIR 1969 Bom 255, for the principle that a complete specification must enable a skilled person to perform the invention without further invention. The Court also relied upon Arti Srivastava v. Assistant Controller of Patents, C.A. (COMM.IPD-PAT) 252/2022 (Delhi High Court, decided on 11 May 2026), which reiterated the necessity of enabling disclosure. Further reliance was placed on The Regents of the University of California v. The Controller of Patents, 2025 SCC OnLine Del 987, and AGFA NV v. Assistant Controller of Patents and Designs, 2023 SCC OnLine Del 3493, both of which emphasized that inadequate disclosure and absence of sufficient technical particulars render a patent specification non-compliant with Section 10.

The appellant had relied upon the decision of the Supreme Court of the United Kingdom in Regeneron Pharmaceuticals Inc. v. Kymab Ltd., [2020] UKSC 27, arguing that the law does not require proof of every possible embodiment within the claimed range. The Court accepted the legal proposition in principle but held that the decision was distinguishable on facts. Unlike Regeneron, the present case did not involve a specification disclosing a general principle capable of practical implementation. Instead, the specification failed to provide the minimum technical information necessary for reproducing the invention, thereby compelling a skilled person to engage in undue experimentation. Consequently, the reliance placed upon Regeneron was held to be misplaced.

The Court also rejected the procedural challenge advanced by the appellant. It held that objections under Section 10 had already been communicated in the First Examination Report and were reiterated in the hearing notice. Since the amendments introduced by the appellant did not substantially alter the specification or remove the deficiencies, there was no legal requirement for a fresh examination under Sections 12, 13 or 14 of the Patents Act. The appellant had sufficient notice of the objections and adequate opportunity to respond. Therefore, there was neither violation of the principles of natural justice nor any procedural irregularity in the Controller's decision-making process.

The Court concluded with a broader observation regarding the philosophy of patent law. It reiterated that patents are intended to teach the public how to perform an invention. A patent specification that leaves critical aspects undisclosed, compels extensive experimentation, or merely describes functional outcomes without practical implementation cannot justify the grant of an exclusive statutory monopoly. The Court described the appellant's specification as effectively "empty" because it disclosed desired results without providing an enabling pathway for achieving them.

Final Decision of the Court

After considering the statutory framework, the rival submissions and the technical material on record, the Court found no illegality, perversity or procedural irregularity in the Controller's order rejecting the patent application.

The Court held that the patent specification failed to satisfy the mandatory requirements of Sections 10(4) and 10(5) of the Patents Act, 1970. It also held that the omission to disclose the source and geographical origin of the biological material constituted an independent ground for refusal.

Accordingly, the appeal was dismissed, and the order dated 24 May 2024 passed by the Controller of Patents rejecting Patent Application No. 202137013369 under Section 15 of the Patents Act was affirmed.

Point of Law Settled:

The judgment reinforces that compliance with Section 10 of the Patents Act, 1970 is mandatory and not merely procedural. A patent applicant must provide an enabling disclosure that permits a person skilled in the relevant art to perform the invention without undue experimentation. Broad claims unsupported by sufficient technical disclosure, absence of working examples, vague operational parameters, or failure to disclose the source and geographical origin of biological material will render a patent specification legally insufficient.

The decision also clarifies that disclosure of the source and geographical origin of biological material is mandatory whenever such material is used in an invention, irrespective of whether the biological material itself forms the subject matter of the patent claim. This judgment is likely to serve as an important precedent in biotechnology and pharmaceutical patent prosecutions by reaffirming the principle that exclusive patent rights are granted only in exchange for complete, clear and enabling disclosure.

Title of the Case: Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschunge v. The Controller General of Patents, Designs and Trade Marks & Anr.

Date of Judgment/Order: 17.06.2026

Case Number: IPDPTA/11/2024

Name of Court: High Court at Calcutta

Name of Hon'ble Judge: Justice Ravi Krishan Kapur

Written By:Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi

Disclaimer:Images used herein do not reflect actual images used in the Judgment and are intended solely for illustrative purposes. Readers are advised not to treat this article as a substitute for legal advice as it may contain errors in perception, interpretation, and presentation. The article is prepared for general informational and educational purposes only.

Suggested SEO Titles

1. Calcutta High Court Upholds Rejection of Patent for Insufficient Disclosure under Section 10 of the Patents Act

2. Patent Specification Must Enable Skilled Person: Calcutta High Court Clarifies Section 10 Requirements

3. Biological Material Disclosure Mandatory in Patent Applications: Calcutta High Court Judgment Explained

4. Fraunhofer v Controller General of Patents: Landmark Ruling on Sufficiency of Disclosure

5. Complete Disclosure is Essential for Patent Grant: Calcutta High Court IPD Decision

6. Patent Law Update 2026: Calcutta High Court on Enabling Disclosure and Biological Material

7. Section 10 of the Patents Act Explained through Fraunhofer Patent Case

8. Patent Rejection Upheld for Vague Claims and Inadequate Specification: High Court Analysis

9. Important Patent Judgment on Sufficiency of Disclosure and Biopiracy Compliance

10. Calcutta High Court Strengthens Patent Disclosure Standards under the Patents Act

11. Patent Drafting Lessons from Fraunhofer v Controller General of Patents

12. How Indian Courts Interpret Sufficiency of Disclosure in Patent Applications

Suggested SEO Tags

Patent Law India, Patents Act 1970, Section 10 Patents Act, Section 15 Patents Act, Patent Specification, Sufficiency of Disclosure, Enabling Disclosure, Patent Drafting, Patent Litigation India, Patent Prosecution, Intellectual Property Law, Biotechnology Patent, Biological Material Disclosure, Geographical Origin Biological Material, Patent Examination, Controller of Patents, Patent Appeal, Calcutta High Court IPD, Intellectual Property Rights Division, Patent Rejection, Patent Claims, Patent Law Update 2026, Biopiracy, Budapest Treaty, Patent Practice India, Indian Patent Law, Patent News India, Patent Attorney India, Patent Jurisprudence, AdvocateAjayAmitabhSuman, IPAdjutor

Headnote of the Judgment

Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschunge v. The Controller General of Patents, Designs and Trade Marks & Anr., decided by the High Court at Calcutta (Intellectual Property Rights Division) in IPDPTA/11/2024, concerned an appeal challenging rejection of a patent application under Section 15 of the Patents Act, 1970. The Court held that the complete specification failed to satisfy the mandatory requirements of Sections 10(4) and 10(5) as it lacked enabling disclosure, working examples, clarity, and omitted disclosure of the source and geographical origin of the biological material used in the invention. Holding that patents can be granted only upon complete, clear and enabling disclosure, the Court dismissed the appeal and upheld the Controller's rejection of the patent application.

Info-Graphic Thumbnail Prompt

**Create a premium 3D hyper-realistic 8K legal infographic thumbnail in 14:9 aspect ratio depicting an advanced biotechnology laboratory with a futuristic bioreactor emitting subtle blue and amber illumination. Display a partially transparent patent specification document with highlighted technical diagrams, scientific formulae and claim sheets being examined under a glowing digital legal dashboard. Show realistic DNA strands, microscopic biological cells, laboratory glassware, radiation beams and holographic patent validation icons. Include a bold red "PATENT REJECTED" style stamp, broken patent seal, warning indicators and a metallic balance of justice to symbolise judicial scrutiny. Use premium black, deep red, metallic gold and silver colour palette with glowing amber highlights, cinematic lighting, realistic reflections, ultra-sharp textures, volumetric lighting and modern intellectual property aesthetics. Keep text extremely minimal using only phrases such as "Patent Rejected", "Section 10", and "Insufficient Disclosure". Avoid clutter. Use realistic 3D charts, legal dashboards, technical illustrations and visual storytelling instead of text-heavy graphics. Do not use the name of any Court, Judge, lawyer, national flag, Ashoka Emblem or any government insignia. Use generic legal and scientific imagery only. Use attached image as Image of lawyer in lawyers dress at left bottom corner which should cover 20% of entire image area.

Thursday, June 25, 2026

SC-Milmet Oftho Industries & Ors. v. Allergan Inc.

Milmet Oftho Industries v. Allergan Inc.: Supreme Court Clarifies Global Reputation, First-in-the-Market Rule and Protection of Pharmaceutical Trademarks

Introduction

The decision of the Supreme Court in Milmet Oftho Industries & Ors. v. Allergan Inc. is one of the most significant judgments in Indian trademark jurisprudence concerning pharmaceutical products, trans-border reputation, and passing-off actions involving multinational corporations and Indian companies. The case addressed a recurring issue in an increasingly globalized marketplace: whether a foreign pharmaceutical company that has established reputation and prior use of a trademark internationally can restrain an Indian company from using the same mark in India, even when the foreign company has not yet commenced actual sales in the Indian market.

The judgment is particularly important because it balances two competing interests. On one hand, it recognizes the growing importance of international reputation and global goodwill in pharmaceutical trademarks. On the other hand, it cautions that multinational corporations should not be permitted to block Indian enterprises merely by claiming worldwide use of a mark without any genuine intention of entering the Indian market.

The decision continues to be a leading authority on trans-border reputation, passing off, pharmaceutical trademarks, and the principle that the ultimate inquiry in such disputes is often to determine who was first in the market.

Factual and Procedural Background

The dispute arose between Milmet Oftho Industries and others, an Indian pharmaceutical company, and Allergan Inc., a multinational pharmaceutical corporation engaged in the manufacture and sale of pharmaceutical products across several countries.

The controversy concerned the trademark “OCUFLOX,” which was used in relation to medicinal products intended for eye care and ophthalmic treatment. Allergan claimed that it had adopted and first used the mark “OCUFLOX” on 9 September 1992 in connection with an ophthalmic preparation containing Ofloxacin and related compounds. According to Allergan, the product had thereafter been marketed in various countries including Europe, Australia, South Africa, South America, Canada, Mexico, Peru, Bolivia, Ecuador, and the United States. Allergan had also secured trademark registrations in several jurisdictions and had filed applications for registration in India and other countries.

Milmet Oftho Industries, meanwhile, was marketing a medicinal product under the identical mark “OCUFLOX.” The Indian company contended that it had independently coined the mark by combining the prefix “OCU” derived from the word “ocular” and “FLOX” derived from “Ciprofloxacin,” which was a principal ingredient of its product. The company had obtained permission from the Food and Drug Control Administration on 25 August 1993 and had also applied for registration of the mark in September 1993.

Allergan instituted a passing-off action seeking an injunction against the use of the mark by the Indian company. An ad interim injunction was initially granted on 18 December 1996. However, the Single Judge later vacated the injunction on 29 January 1997, holding that Allergan's product was not being sold in India and that Milmet had introduced its product in the Indian market earlier.

Allergan challenged the order before the Division Bench of the Calcutta High Court. The Division Bench reversed the Single Judge’s decision and held that Allergan was the first in the market and therefore entitled to protection. Aggrieved by this decision, Milmet Oftho Industries approached the Supreme Court by way of appeal.

Dispute Before the Court

The principal question before the Supreme Court was whether a foreign pharmaceutical company that had adopted and used a trademark internationally before an Indian company could restrain the Indian company from using the same mark in India, even though the foreign company had not yet commenced actual sales of the product in India.

The case also required the Court to examine the principles governing passing-off actions involving medicinal products, the relevance of trans-border reputation, and the extent to which international use and advertising could confer rights enforceable in India.

Allergan argued that it was the prior adopter and prior user of the mark “OCUFLOX” globally and had established goodwill and reputation across multiple jurisdictions. It contended that permitting the Indian company to use the identical mark would create confusion in the pharmaceutical market and damage its reputation.

Milmet Oftho Industries contended that it had independently developed the mark, had obtained regulatory approvals in India, and was the first company to market products under the mark within India. It argued that a company not trading in India should not be entitled to restrain a domestic enterprise from carrying on legitimate business activities.

Reasoning and Analysis of the Court

The Supreme Court began by examining the settled principles governing passing-off actions. The Court referred extensively to the landmark decision in N.R. Dongre v. Whirlpool Corporation, MANU/SC/0395/1996, which recognized the doctrine of trans-border reputation and held that a passing-off action can be maintained even against a registered proprietor where the plaintiff enjoys superior goodwill and reputation. The Court noted that in Whirlpool, the mark had acquired substantial international recognition and its reputation extended into India despite limited commercial activity within the country.

The Court also relied upon Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd., 2001 PTC 300 (SC), a leading decision concerning deceptive similarity in pharmaceutical trademarks. The Court reiterated the factors laid down in Cadila for assessing deceptive similarity, including the nature of the marks, degree of resemblance, nature of goods, similarity in character and performance, class of purchasers, mode of purchase, and surrounding circumstances.

The Court emphasized that medicinal products require a much higher degree of judicial scrutiny than ordinary consumer goods. Confusion in pharmaceutical products can have serious consequences affecting public health and patient safety. The Court noted that mistakes can occur even among trained medical professionals and pharmacists, particularly because prescriptions are often handwritten or communicated telephonically. Consequently, courts must adopt a stricter approach when evaluating similarity between pharmaceutical marks.

While discussing modern commercial realities, the Court observed that the pharmaceutical industry had acquired a distinctly international character. Medical professionals routinely access international medical literature, attend global conferences, and remain informed about developments in pharmaceutical products worldwide. The widespread availability of advertising and medical information enables pharmaceutical products to acquire reputation across national borders. Therefore, a mark associated with a particular drug internationally may already enjoy recognition among medical professionals and consumers in India even before the product is physically introduced into the country.

The Court held that permitting identical marks for similar pharmaceutical products could create confusion and potentially endanger public interest. Consequently, courts must consider not merely domestic sales but also international reputation and prior adoption.

However, the Supreme Court introduced an important qualification. It cautioned that multinational corporations should not be allowed to monopolize marks in India merely on the basis of foreign reputation if they have no genuine intention of entering the Indian market. Such an approach could unfairly suppress Indian enterprises that have honestly adopted a mark and developed their products independently. The Court therefore stated that the ultimate test should be determining who was first in the market.

Applying these principles to the facts, the Court noted that the Division Bench had relied upon material indicating that Allergan's product had been advertised and promoted before Milmet entered the field. This material prima facie suggested that Allergan was the first adopter and user of the mark. Therefore, the Division Bench’s conclusion granting protection to Allergan could not be faulted at the interlocutory stage.

At the same time, the Court recognized that the appellants disputed Allergan's claim of prior adoption and argued that the evidence was insufficient to establish first use. Since these issues required a detailed examination of evidence, the Court concluded that they should be decided during trial rather than at the interim stage.

Final Decision of the Court

The Supreme Court declined to interfere with the injunction operating against Milmet Oftho Industries and directed that the injunction should continue pending final adjudication of the suit.

The Court observed that the appellants had already been marketing their product under an alternative name because of the injunction and that the balance of convenience favoured maintaining the existing arrangement until the evidence was fully examined. The Court clarified that if Allergan ultimately proved prior adoption and prior use of the mark, it would be entitled to permanent protection. Conversely, if the evidence established that Allergan had not adopted the mark prior to its use by the Indian company, the trial court would be free to vacate the injunction and assess damages suffered by the appellants.

The appeal was disposed of without costs. The Supreme Court further directed that the suit be expedited and requested the trial court to dispose of it as early as possible, preferably within six months.

Point of Law Settled

The judgment establishes and clarifies several important principles of trademark law.

First, in cases involving pharmaceutical products, courts must apply a stricter standard when assessing deceptive similarity because confusion may adversely affect public health and safety.

Second, trans-border reputation is a legally recognized concept in India. A foreign company may obtain protection against passing off even if its products are not yet physically sold in India, provided it can establish prior adoption, reputation, and goodwill extending into the Indian market.

Third, the Court recognized that globalization and the international flow of information have transformed the assessment of trademark reputation, particularly in the pharmaceutical sector.

Most importantly, the judgment introduced a significant caveat that multinational corporations should not be permitted to prevent Indian companies from using a mark where the foreign company has no genuine intention of entering the Indian market. The Court emphasized that the ultimate test in such disputes is to determine who is truly first in the market.

The decision remains one of the leading authorities governing trans-border reputation, pharmaceutical trademarks, and passing-off actions in India.

I have reviewed the uploaded judgment Milmet Oftho Industries & Ors. v. Allergan Inc., (2004) 12 SCC 624; 2004 (28) PTC 585 (SC) and prepared the following publication-ready analytical legal article.

Milmet Oftho Industries v. Allergan Inc.: Supreme Court Clarifies Global Reputation, First-in-the-Market Rule and Protection of Pharmaceutical Trademarks

Introduction

The decision of the Supreme Court in Milmet Oftho Industries & Ors. v. Allergan Inc. is one of the most significant judgments in Indian trademark jurisprudence concerning pharmaceutical products, trans-border reputation, and passing-off actions involving multinational corporations and Indian companies. The case addressed a recurring issue in an increasingly globalized marketplace: whether a foreign pharmaceutical company that has established reputation and prior use of a trademark internationally can restrain an Indian company from using the same mark in India, even when the foreign company has not yet commenced actual sales in the Indian market.

Factual and Procedural Background

Dispute Before the Court

Reasoning and Analysis of the Court

The Supreme Court began by examining the settled principles governing passing-off actions. The Court referred extensively to the landmark decision in N.R. Dongre v. Whirlpool Corporation, MANU/SC/0395/1996, which recognized the doctrine of trans-border reputation and held that a passing-off action can be maintained even against a registered proprietor where the plaintiff enjoys superior goodwill and reputation. The Court noted that in Whirlpool, the mark had acquired substantial international recognition and its reputation extended into India despite limited commercial activity within the country.

The Court also relied upon Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd., 2001 PTC 300 (SC), a leading decision concerning deceptive similarity in pharmaceutical trademarks. The Court reiterated the factors laid down in Cadila for assessing deceptive similarity, including the nature of the marks, degree of resemblance, nature of goods, similarity in character and performance, class of purchasers, mode of purchase, and surrounding circumstances.

Final Decision of the Court

The Supreme Court declined to interfere with the injunction operating against Milmet Oftho Industries and directed that the injunction should continue pending final adjudication of the suit.

Point of Law Settled

The judgment establishes and clarifies several important principles of trademark law.

First, in cases involving pharmaceutical products, courts must apply a stricter standard when assessing deceptive similarity because confusion may adversely affect public health and safety.

Third, the Court recognized that globalization and the international flow of information have transformed the assessment of trademark reputation, particularly in the pharmaceutical sector.

The decision remains one of the leading authorities governing trans-border reputation, pharmaceutical trademarks, and passing-off actions in India.

Case Details

Title of the Case: Milmet Oftho Industries & Ors. v. Allergan Inc.

Date of Judgment/Order: 07 May 2004

Case Number: Civil Appeal No. 5791 of 1998

Neutral Citation: MANU/SC/0512/2004

Equivalent Citations: (2004) 12 SCC 624; 2004 (28) PTC 585 (SC)

Name of Court: Supreme Court of India

Name of Hon'ble Judge: Justice S.N. Variava and Justice H.K. Sema

Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi

Disclaimer: Images used herein do not reflect actual images used in Judgement and that the same are for illustrative purpose only. Readers are advised not to treat this as substitute for legal advice as it may contain errors in perception, interpretation, and presentation.

Suggested SEO Titles

1. Milmet Oftho Industries v Allergan Inc Explained: Supreme Court on Trans-Border Reputation

2. Supreme Court Clarifies First-in-the-Market Rule in Pharmaceutical Trademark Disputes

3. Milmet v Allergan: Landmark Judgment on Global Trademark Rights in India

4. Pharmaceutical Trademark Protection in India After Milmet Oftho Industries Case

5. Trans-Border Reputation and Passing Off: Analysis of Milmet v Allergan

6. Can a Foreign Company Protect Its Trademark in India Without Selling Products Here?

7. Supreme Court on International Reputation and Pharmaceutical Trademarks

8. Milmet Oftho Industries Judgment: Passing Off and Global Goodwill Explained

9. OCUFLOX Trademark Dispute and the Evolution of Indian Trademark Law

10. Leading Supreme Court Decision on Pharmaceutical Trademark Confusion and Public Safety

Suggested SEO Tags

Milmet Oftho Industries, Allergan Inc, OCUFLOX trademark dispute, trans border reputation, pharmaceutical trademarks, passing off action, trademark infringement India, international trademark rights, first in the market rule, pharmaceutical brand protection, deceptive similarity, Cadila Health Care case, Whirlpool case, trademark law India, intellectual property litigation, pharmaceutical trademark dispute, multinational trademark rights, global goodwill trademark, passing off jurisprudence, trademark protection India, ophthalmic products trademark, medicinal products trademark, Supreme Court trademark judgment, trademark enforcement, pharmaceutical branding disputes, intellectual property rights India, transnational reputation, AdvocateAjayAmitabhSuman, IPAdjutor

Headnote of the Judgment

Milmet Oftho Industries & Ors. v. Allergan Inc., decided by the Supreme Court of India in Civil Appeal No. 5791 of 1998, concerned a passing-off dispute relating to the pharmaceutical trademark “OCUFLOX.” The appeal arose from a Calcutta High Court decision granting injunction in favour of Allergan Inc. The Supreme Court held that in pharmaceutical trademark disputes, trans-border reputation and prior international adoption of a mark are relevant considerations. The Court emphasized that the ultimate test is who is first in the market while cautioning that multinational corporations without genuine intention to enter India should not be permitted to unfairly restrain Indian businesses. The injunction was allowed to continue pending trial and the suit was directed to be expedited.

Info-graphic Thumbnail Prompt

Create a premium 3D hyper-realistic 8K legal-news infographic thumbnail in 14:9 aspect ratio illustrating a landmark pharmaceutical trademark dispute involving the identical mark “OCUFLOX”. Show two competing medicine packages facing each other across a glowing legal battlefield, with one side representing global brand reputation and the other representing local market adoption. Central focus on a luminous trademark shield, global pharmaceutical network map, interconnected medical research hubs, reputation flow graphics, anti-confusion warning symbols, brand ownership dashboards, legal scales, intellectual property protection barriers, and advanced pharmaceutical branding analytics. Use premium red, gold, black, metallic silver, and glowing amber highlights with ultra-sharp details, cinematic lighting, realistic reflections, strong contrast, and modern intellectual property law aesthetics. Include subtle visual representation of “Global Reputation vs First in Market” using elegant icons and charts. Use very little text, limited to “OCUFLOX” and “TRADEMARK DISPUTE”. Avoid clutter. Use realistic 3D charts, legal dashboards, tables, and visual storytelling rather than large blocks of text. Do not use the name of any court, lawyer, judge, tricolor, Ashoka Emblem, or any government insignia. Use generic pharmaceutical, intellectual property, and legal imagery only. Use attached image as Image of lawyer in lawyers dress at left bottom corner which should cover 20 % of entire image area.

SC-London Rubber Co. Ltd. Vs Durex Products Incorporated

London Rubber Co. Ltd. v. Durex Products Incorporated: Supreme Court Clarifies Honest Concurrent Use in Trademark Registration

Introduction

The decision of the Supreme Court in London Rubber Co. Ltd. v. Durex Products Incorporated is one of the foundational judgments in Indian trademark law concerning the doctrine of honest concurrent use. The case addressed a recurring problem in trademark jurisprudence: whether registration of a trademark that is identical or similar to another mark can nevertheless be permitted when both parties have honestly and concurrently used the mark over a substantial period.

The judgment is significant because trademark law seeks to balance competing interests. On one hand, it protects the rights of trademark proprietors and safeguards consumers against confusion. On the other hand, it recognizes commercial realities where different traders may honestly adopt and use similar marks over long periods without causing actual confusion. The Supreme Court examined the scope of Section 10(2) of the Trade Marks Act, 1940, and clarified how honest concurrent use and special circumstances operate as exceptions to the general prohibition against registration of identical or deceptively similar trademarks.

The ruling remains an important authority for trademark practitioners, businesses, intellectual property professionals, trademark registries, and courts dealing with registration disputes involving competing claims over similar marks.

Factual and Procedural Background

The dispute arose between London Rubber Co. Ltd., the appellant, and Durex Products Incorporated, the respondent, regarding the trademark “DUREX.” The appellant objected to the registration sought by the respondent in India on the ground that the mark was identical or deceptively similar to its own trademark rights and that such registration was prohibited under the Trade Marks Act.

The respondent, a corporation incorporated in New York, had been manufacturing and marketing contraceptive products under the trademark “DUREX” for many years. Evidence was produced showing that the respondent had been using the mark since the late 1920s and had exported substantial quantities of goods bearing the mark to India for several decades. The respondent contended that its use of the trademark in India was honest, continuous, and commercial in nature.

The matter came before the Deputy Registrar of Trade Marks, who concluded that the respondent had established honest concurrent use and that special circumstances existed justifying registration. The registration was accordingly permitted.

The appellant challenged this decision before the Calcutta High Court. The High Court upheld the findings of the Deputy Registrar and held that the respondent had successfully established honest concurrent use of the mark. The Court further held that special circumstances existed which independently justified registration.

Aggrieved by the decision of the High Court, the appellant approached the Supreme Court, raising important questions regarding the interpretation of Section 10(2) of the Trade Marks Act, 1940 and the extent of discretion available to the Registrar in permitting registration despite similarity of marks.

Dispute Before the Court

The principal issue before the Supreme Court was whether the respondent's trademark could be registered despite the existence of another similar mark and whether the case fell within the exception contained in Section 10(2) of the Trade Marks Act, 1940.

The appellant argued that the statutory prohibition against registration of identical or similar marks should prevail and that the Registrar lacked authority to permit registration in circumstances where confusion or deception was possible. According to the appellant, the provisions relating to honest concurrent use should be interpreted narrowly.

The respondent contended that Section 10(2) was specifically enacted as an exception to the general prohibition contained in the Act and empowered the Registrar to permit registration where honest concurrent use or special circumstances were established. The respondent emphasized its long-standing commercial use of the mark in India and argued that there was no evidence of actual confusion among consumers.

The Court was therefore required to determine the scope of the Registrar's discretion, the meaning of honest concurrent use, the significance of the volume of use, and the circumstances in which special circumstances could justify registration.

Reasoning and Analysis of the Court

The Supreme Court began by examining the scheme of the Trade Marks Act, 1940. The Court observed that Sections 8(a) and 10(1) contained prohibitory provisions intended to prevent registration of marks likely to cause confusion or deception. However, Section 10(2) constituted an express exception to those prohibitions. The Court emphasized that the language used by the legislature required full effect to be given to the statutory exception and that it could not be interpreted so narrowly as to defeat its purpose.

The Court rejected the contention that Section 10(2) could operate only where a conflicting mark was already on the register. Such an interpretation, according to the Court, would produce irrational and anomalous results and would undermine the legislative scheme. The Court held that the provision was intended to confer discretionary power upon the Registrar in appropriate cases involving honest concurrent use.

While discussing the relationship between the prohibition against deceptive marks and the exception based on honest concurrent use, the Court referred to the English decision in Bass v. Nicholson & Sons Ltd., (1932) 49 RPC 88, where it was recognized that a trademark is not necessarily denied registration merely because some possibility of confusion exists. The judgment relied upon the principle that statutory provisions relating to honest concurrent use may override the general prohibition in appropriate cases.

The Court also referred to Spillers Ltd.'s Application, (1952) 69 RPC 327, where Danckwerts J. explained that the provisions governing confusion and those relating to honest concurrent use must be read harmoniously rather than as isolated compartments. The Supreme Court found this reasoning persuasive and accepted the proposition that a tribunal may exercise discretion under the honest concurrent use provision even where questions of confusion arise.

Further support was drawn from Halsbury's Laws of England, which states that statutory recognition of honest concurrent use may overcome objections based on likelihood of confusion where evidence demonstrates long and honest use without actual confusion.

The Court then turned to the factual question of honest concurrent use. It observed that the respondent had produced evidence demonstrating substantial commercial use of the trademark “DUREX” in India over a long period. Affidavits established that significant quantities of goods bearing the mark had been exported to India since approximately 1930. Both the Deputy Registrar and the High Court had accepted this evidence.

A particularly important aspect of the judgment concerns the concept of volume of use. The appellant argued that the respondent's use was insufficient to qualify as honest concurrent use. Rejecting this argument, the Court held that no rigid rule could be formulated regarding the volume of use necessary under Section 10(2). What is essential is genuine commercial use rather than isolated or token use. The Court endorsed the High Court's view that even a comparatively small trader may establish honest concurrent use if the use is bona fide and commercial in nature. Trade mark rights are a form of property and deserve protection regardless of the scale of business, provided they possess commercial significance.

The Supreme Court also considered the alternative ground of “special circumstances.” The High Court had identified several circumstances supporting registration, including the fact that “DUREX” formed part of the respondent company's own corporate name, the exceptionally long duration of use, the hardship that would result from refusing registration after decades of use, and the distinction between the respective goods involved. The Supreme Court agreed that most of these circumstances were relevant and capable of constituting special circumstances within the meaning of Section 10(2).

The Court referred to Holt & Co. (Leeds) Ltd.'s Application, (1957) RPC 289, where it was held that special circumstances include circumstances peculiar to the application and the subject matter of the application, including prior use of the mark before the conflicting mark was registered or used. The Supreme Court endorsed this interpretation.

Finally, the Court examined whether there existed any reasonable probability of confusion. It noted that there had been no actual instance of confusion despite extensive and prolonged use. The Court also observed that the respondent's goods were distinct in character and usage. In these circumstances, the possibility of deception or confusion was minimal.

Final Decision of the Court

The Supreme Court upheld the judgment of the Calcutta High Court and affirmed the order permitting registration of the respondent's trademark.

The Court held that the respondent had successfully established honest concurrent use of the trademark over a substantial period. It further held that several special circumstances existed which independently justified registration under Section 10(2) of the Trade Marks Act, 1940.

Accordingly, the appeal was dismissed with costs and the respondent's registration was sustained.

Point of Law Settled

The judgment authoritatively establishes that the doctrine of honest concurrent use constitutes a genuine statutory exception to the general prohibition against registration of identical or similar trademarks.

The Supreme Court clarified that no rigid or mathematical standard exists regarding the volume of use required to establish honest concurrent use. The decisive consideration is whether the use is genuine, commercial, honest, and substantial in the context of the applicant's business.

The decision further explains that “special circumstances” under trademark law are not narrowly confined and may include long-standing use, hardship arising from refusal of registration, prior use, use of a corporate name, and other circumstances directly connected with the trademark and its commercial history.

The judgment continues to be a leading precedent governing concurrent trademark rights, discretionary registration, and the balance between private trademark rights and commercial realities.

Case Details:

Title of the Case: London Rubber Co. Ltd. Vs Durex Products Incorporated

Date of Judgment/Order: 1963

Case Number: Civil Appeal No. 195 of 1962

Neutral Citation: AIR 1963 SC 1882

Equivalent Citation: MANU/SC/0187/1963

Name of Court: Supreme Court of India

Name of Hon'ble Judge: Hon'ble Mr. Justice J.C. Shah and Hon'ble Mr. Justice K.N. Wanchoo

Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi

Disclaimer: Images used herein do not reflect actual images used in Judgement and that the same are for illustrative purpose only. Readers are advised not to treat this as substitute for legal advice as it may contain errors in perception, interpretation, and presentation.

Suggested SEO Titles:

London Rubber Co. v. Durex Products: Landmark Supreme Court Ruling on Honest Concurrent Use
Honest Concurrent Use Under Trademark Law Explained Through the DUREX Case
Supreme Court on Registration of Similar Trademarks: London Rubber Decision
Special Circumstances in Trademark Registration: Analysis of London Rubber v Durex
DUREX Trademark Case: Supreme Court Clarifies Section 10(2) of Trade Marks Act
Honest Concurrent Use and Trademark Registration in India
Leading Supreme Court Judgment on Trademark Registration and Concurrent Rights
When Can Similar Trademarks Coexist? Supreme Court Explains
London Rubber Co. Ltd. v. Durex Products Incorporated: Complete Legal Analysis
Trademark Registration Despite Similarity: The Honest Concurrent Use Doctrine

Suggested SEO Tags:

London Rubber Co Ltd, Durex Products Incorporated, DUREX trademark case, honest concurrent use, trademark registration India, Section 10(2) Trade Marks Act, special circumstances trademark law, trademark jurisprudence India, Supreme Court trademark judgment, concurrent trademark rights, deceptive similarity, trademark registration exception, intellectual property law India, trade mark litigation, trademark opposition, trademark registry powers, trademark coexistence, Bass v Nicholson, Spillers Application, Holt and Co Application, Halsbury Laws of England trademarks, commercial use trademark, trademark precedent India, registration of similar trademarks, trademark legal analysis, passing off and trademarks, trademark disputes India, AdvocateAjayAmitabhSuman, IPAdjutor

Headnote of the Judgment:

London Rubber Co. Ltd. v. Durex Products Incorporated, Supreme Court of India, Civil Appeal No. 195 of 1962, AIR 1963 SC 1882. The appeal challenged the registration of the trademark “DUREX” in favour of Durex Products Incorporated. The principal issue was whether registration could be permitted despite similarity with another mark by invoking the doctrine of honest concurrent use under Section 10(2) of the Trade Marks Act, 1940. The Supreme Court held that honest concurrent use constitutes a statutory exception to the general prohibition against registration of similar trademarks. Finding long-standing commercial use, absence of confusion, and existence of special circumstances, the Court upheld the registration and dismissed the appeal with costs.

Info-graphic Thumbnail Prompt:

Create a premium 3D hyper-realistic 8K legal-news infographic thumbnail in 14:9 aspect ratio depicting a landmark trademark registration dispute involving honest concurrent use. Central focus on two competing glowing trademark certificates bearing similar branding elements connected by a golden balance scale labelled “HONEST CONCURRENT USE”. Show realistic 3D intellectual property dashboards, trademark registry databases, registration approval seals, coexistence analytics, commercial goodwill graphs, legal precedent charts, confusion-risk indicators, and glowing legal data visualizations. Use premium red, gold, black, metallic silver, and glowing amber highlights with ultra-sharp details, cinematic lighting, realistic reflections, dramatic contrast, and sophisticated intellectual property law aesthetics. Keep text minimal and highly readable with only “DUREX CASE” and “HONEST CONCURRENT USE”. Use realistic 3D charts, legal dashboards, tables, and visual storytelling rather than large blocks of text. Avoid clutter. Do not use the name of any court, lawyer, judge, tricolor, Ashoka Emblem, government insignia, or official seals. Use generic legal and trademark imagery only. Use attached image as Image of lawyer in lawyers dress at left bottom corner which should cover 20% of entire image area.

SC-Laxmikant V. Patel Vs Chetanbhat Shah

Laxmikant V. Patel v. Chetanbhat Shah & Anr.: Supreme Court Strengthens Protection of Trade Names and Passing Off Rights

Introduction

The decision of the Supreme Court in Laxmikant V. Patel v. Chetanbhat Shah & Anr. is one of the most important judgments in Indian trademark and passing off jurisprudence. The case concerns the protection of business goodwill associated with a trade name and the circumstances in which courts should grant interim injunctions to prevent passing off. The judgment is frequently cited for its authoritative exposition of the law relating to trade names, goodwill, business reputation, deceptive similarity, and interim relief.

The significance of the decision extends far beyond trademark registration disputes. The Supreme Court clarified that even where a business name is not a registered trademark, the goodwill associated with that name constitutes a valuable proprietary right deserving legal protection. The ruling is particularly important for small and medium businesses, professional service providers, traders, entrepreneurs, and intellectual property practitioners because it recognizes that reputation painstakingly built over time cannot be appropriated by competitors through deceptively similar business names.

The judgment also provides valuable guidance regarding the grant of temporary injunctions in passing off actions and emphasizes that honesty and fair play remain fundamental principles governing commercial activities.

Factual and Procedural Background

The appellant, Laxmikant V. Patel, was carrying on the business of colour laboratory and photographic studio services in Ahmedabad under the name and style of “Muktajivan Colour Lab and Studio.” According to the appellant, the business had commenced in 1982 and over the years had acquired substantial goodwill and reputation among customers. Considerable expenditure had been incurred on advertising, promotional activities, signboards, stationery, invoices, albums, and other business materials prominently displaying the word “Muktajivan.”

As the business expanded, additional establishments were opened by the appellant’s wife and relatives at different locations in Ahmedabad using the name “Muktajivan” as part of their business identity. The appellant claimed that the name had become closely associated in the minds of consumers with the quality and reputation of his photographic services.

The dispute arose when the first respondent, who had previously been carrying on a similar business under the name “Gokul Studio,” proposed to commence business through his wife under the name “Muktajivan Colour Lab and Studio.” The appellant alleged that the adoption of the identical business name was intended to exploit the goodwill already established by him and to mislead customers into believing that the respondents’ business was associated with or connected to his business.

On 12 May 1997, the appellant instituted a passing off action before the District Court at Ahmedabad seeking a permanent injunction restraining the respondents from passing off their business, services, and goods as those of the appellant. Along with the suit, an application for interim injunction was also filed. Initially, an ex parte order was granted. However, after hearing both parties, the Trial Court dismissed the injunction application.

The Trial Court found that the respondents had recently adopted the word “Muktajivan” and that their business name was substantially similar to that of the appellant. Nevertheless, the Court refused injunction primarily because the businesses were situated approximately four to five kilometres apart in Ahmedabad.

The appellant challenged the decision before the Gujarat High Court. The High Court dismissed the appeal and vacated the interim protection. It held that the respondents’ business had already commenced and that the appellant could not seek preventive relief. It further questioned the appellant’s interest in certain related business establishments operated by family members.

Aggrieved by these findings, the appellant approached the Supreme Court.

Dispute Before the Court

The central issue before the Supreme Court was whether the respondents could be restrained from using the trade name “Muktajivan Colour Lab and Studio” in a business similar to that of the appellant.

The Court was required to determine whether the appellant had established goodwill and reputation in the trade name “Muktajivan,” whether the respondents’ adoption of the same name was likely to cause confusion among consumers, and whether a prima facie case existed for grant of an interim injunction.

The respondents argued that their business was situated at a different location, that the plaintiff had not established exclusive rights over the word “Muktajivan,” and that the business had already commenced before institution of the suit. The appellant contended that geographical distance was irrelevant in modern commercial transactions and that the respondents were attempting to ride upon the goodwill built by the appellant over many years.

Reasoning and Analysis of the Court

The Supreme Court undertook a detailed examination of the legal principles governing passing off actions and protection of trade names. The Court observed that it is common for traders and businessmen to adopt names under which they conduct business and that such names often acquire goodwill and reputation over time. Once a trade name becomes associated with a particular business, it constitutes valuable commercial property deserving legal protection.

The Court referred extensively to authoritative principles contained in Kerly's Law of Trade Marks and Trade Names, observing that a business name ordinarily carries with it goodwill which courts will protect. The Court noted that an action for passing off lies wherever a defendant adopts a name calculated to deceive the public, divert business, or create confusion between two businesses.

The Court emphasized that the law does not permit a person to conduct business in a manner that persuades customers to believe that his goods or services belong to another trader. It observed that commercial morality and fair competition require protection of established business reputation. A competitor cannot benefit from another's goodwill through deceptive practices.

The Court relied upon Oertli v. Bowman (1957 RPC 388) and observed that the essential elements of a passing off action are reputation, likelihood of deception, and likelihood of damage. These principles, though traditionally applied to trademarks, apply equally to trade names.

The judgment also discussed the observations in Salmond & Heuston on the Law of Torts, where passing off is described as a form of injurious falsehood designed to protect business reputation and goodwill from unfair competition.

Turning to interim injunctions, the Supreme Court reiterated the settled principles that a plaintiff must establish a prima facie case, balance of convenience, and likelihood of irreparable injury. The Court emphasized that actual fraud is not necessary in passing off actions. Even absence of dishonest intention is not a defence where the defendant’s conduct is likely to create confusion. Likelihood of damage is sufficient.

Applying these principles, the Court found that the appellant had been using “Muktajivan” as part of his business name at least since 1995 and had acquired substantial goodwill associated with it. The respondents had previously conducted business under the name “Gokul Studio” and only later adopted “Muktajivan.” The Court concluded that the intention to take advantage of the appellant’s reputation was apparent.

The Supreme Court strongly disagreed with the reasoning of the Trial Court and High Court that the distance of four to five kilometres between the businesses was relevant. The Court observed that in a city such distance is insignificant and customers may travel several kilometres to avail better services. Once goodwill and reputation are established, geographical proximity cannot be treated as a decisive factor.

The Court also rejected the contention that there was delay in filing the suit. It noted that the respondents had not clearly established when they had commenced the allegedly infringing business and that the plaintiff had acted promptly upon learning of the threatened injury.

While discussing appellate interference in injunction matters, the Court referred to Wander Ltd. v. Antox India Pvt. Ltd., MANU/SC/0595/1990 and N.R. Dongre v. Whirlpool Corporation, (1996) 5 SCC 714, reiterating that appellate courts ordinarily do not interfere with discretionary orders unless settled principles of law have been ignored. The Court found that both the Trial Court and High Court had failed to apply the established principles governing passing off and interlocutory injunctions, thereby justifying interference.

Final Decision of the Court

The Supreme Court allowed the appeals and set aside the orders of the Trial Court and the Gujarat High Court. It granted an ad interim injunction under Order XXXIX Rules 1 and 2 of the Code of Civil Procedure restraining the respondents from directly or indirectly using the word “Muktajivan” in connection with their colour laboratory and studio business or any other name identical or deceptively similar to the appellant’s trade name.

The Court also awarded costs in favour of the appellant. At the same time, it clarified that the observations made in the judgment were confined to the interlocutory stage and would not prejudice the final adjudication of the suit on merits.

Point of Law Settled

The judgment firmly establishes that goodwill and reputation associated with a trade name constitute valuable commercial property protected by law. An action for passing off is maintainable not only in respect of registered trademarks but also in relation to business names and trade names that have acquired goodwill.

The decision clarifies that the three essential elements of passing off are goodwill or reputation, likelihood of deception, and likelihood of damage. Fraudulent intention is not necessary. Even innocent adoption of a deceptively similar trade name can justify injunctive relief if confusion is likely.

The Supreme Court further held that geographical distance between competing businesses is not decisive where goodwill extends beyond a limited locality. The judgment remains a leading authority on passing off, protection of trade names, and grant of interim injunctions in intellectual property disputes.

Case Details:

Title of the Case: Laxmikant V. Patel Vs Chetanbhat Shah and Another

Date of Judgment/Order: 04 December 2001

Case Number: Civil Appeal Nos. 8266–8267 of 2001

Neutral Citation: MANU/SC/0763/2001

Equivalent Citation: (2002) 3 SCC 65; AIR 2002 SC 275; 2002 (24) PTC 1 (SC)

Name of Court: Supreme Court of India

Name of Hon'ble Judge: Hon'ble Mr. Justice R.C. Lahoti and Hon'ble Mr. Justice K.G. Balakrishnan

Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi

Suggested SEO Titles:

Laxmikant V Patel v Chetanbhat Shah: Supreme Court on Passing Off and Trade Names
Supreme Court Protects Business Goodwill in Muktajivan Colour Lab Case
Passing Off Action Explained Through Laxmikant V Patel Judgment
Landmark Supreme Court Decision on Trade Name Protection
Can a Business Name Be Protected Without Trademark Registration?
Supreme Court on Goodwill, Reputation and Interim Injunctions
Muktajivan Colour Lab Case: Leading Authority on Passing Off
Trade Name Infringement and Passing Off Under Indian Law
Supreme Court Clarifies Law on Deceptively Similar Business Names
Passing Off and Commercial Goodwill: Detailed Analysis of Laxmikant V Patel Case

Suggested SEO Tags:

Laxmikant V Patel, Chetanbhat Shah, passing off action, trade name protection, business goodwill, Muktajivan Colour Lab, trademark law India, passing off law, trade name dispute, deceptive similarity, interim injunction, Order 39 Rule 1 CPC, Order 39 Rule 2 CPC, goodwill and reputation, intellectual property litigation, trademark jurisprudence, business identity protection, unfair competition, commercial goodwill, injunction in trademark cases, Oertli v Bowman, Wander Ltd v Antox India, Whirlpool case, Supreme Court trademark judgment, passing off principles, trade mark and trade name, business reputation law, AdvocateAjayAmitabhSuman, IPAdjutor

Headnote of the Judgment:

Laxmikant V. Patel v. Chetanbhat Shah and Another, Supreme Court of India, Civil Appeal Nos. 8266–8267 of 2001. The appellant sought an injunction restraining the respondents from using the trade name “Muktajivan Colour Lab and Studio” in a competing business. The Trial Court and Gujarat High Court refused interim relief despite finding similarity between the business names. The Supreme Court allowed the appeal, holding that goodwill associated with a trade name is valuable property protected through passing off actions. The Court held that geographical distance between businesses is not decisive where confusion is likely and that a plaintiff who establishes goodwill, likelihood of deception, and likelihood of damage is entitled to protection. An interim injunction was granted restraining the respondents from using the word “Muktajivan” in their business name.

Info-graphic Thumbnail Prompt:

Create a premium 3D hyper-realistic 8K legal-news infographic thumbnail in 14:9 aspect ratio depicting a landmark passing off and trade name dispute. Central focus on two competing glowing business signboards, one reading “MUKTAJIVAN” and the other showing a deceptively similar name being blocked by a golden legal shield. Show realistic 3D business goodwill graphs, customer flow analytics, reputation meters, trademark-style branding assets, legal scales, injunction order documents, glowing anti-confusion visual indicators, and premium intellectual property dashboards. Use premium red, gold, black, metallic silver, and glowing amber highlights with ultra-sharp details, cinematic reflections, dramatic contrast, realistic lighting, and sophisticated legal-news aesthetics. Keep text minimal and highly readable with only “PASSING OFF” and “TRADE NAME PROTECTION”. Use realistic 3D charts, legal dashboards, tables, and visual storytelling rather than large blocks of text. Avoid clutter. Do not use the name of any court, lawyer, judge, tricolor, Ashoka Emblem, government insignia, or official seals. Use generic business and legal imagery only. Use attached image as Image of lawyer in lawyers dress at left bottom corner which should cover 20% of entire image area.

Mr. P. C. Duraisamy Vs. Kewal Krishan Kumar & Anr.

Mr. P. C. Duraisamy Vs. Kewal Krishan Kumar :24.06.2026 : CO(COMM.IPD-TM) 180/2022 : 2026:DHC:5159 :H,J. Tushar Rao Gedela

The Court considered a dispute concerning rectification of the Trade Marks Register and cancellation of the registered trademark "SHAKTI" under the Trade Marks Act, 1999. The case arose from allegations that the registered proprietor had neither genuinely used the trademark from the date of its application nor established honest and concurrent use, despite obtaining registration.

The principal question before the Court was whether the registration of the trademark "SHAKTI" was liable to be removed from the Register under Sections 47(1)(a) and 57(2) of the Trade Marks Act, 1999.

After examining the material on record and the submissions of the parties, court observed that there was no documentary or tangible evidence demonstrating genuine commercial use of the trademark from the date of application until its registration or thereafter. The Court held that the statutory requirements for maintaining the registration had not been satisfied and that the plea of honest and concurrent use was unsupported by evidence. Emphasizing that a trademark cannot continue on the Register merely on the strength of registration without proof of bona fide use, the Court directed removal of the trademark "SHAKTI" from the Register of Trade Marks within four weeks and disposed of the petition without any order as to costs.

Disclaimer: Readers are advised not to treat this as a substitute for legal advice as it is based on limited information and is intended solely for general informational purposes.

===

Section 47 (1) (a) of Trademarks Act and Rectification

Introduction

The law relating to trademarks is designed not merely to protect registered rights but also to ensure that the Register of Trade Marks reflects marks that are genuinely used in trade. A registered trademark is a valuable commercial asset, but the law does not permit a proprietor to retain exclusive rights over a mark that has not been honestly and continuously used in connection with goods or services. The decision of the Delhi High Court in Mr. P. C. Duraisamy v. Kewal Krishan Kumar & Anr. is an important illustration of this principle.

The judgment examines the circumstances in which a registered trademark can be removed from the Register on the ground of non-use and clarifies the evidentiary burden resting upon a registered proprietor who seeks to justify continued registration. The Court also considered the scope of Sections 47 and 57 of the Trade Marks Act, 1999 and analysed whether the proprietor could successfully rely upon the doctrine of honest and concurrent use despite the absence of credible evidence of actual commercial use.

The decision is significant for trademark proprietors, businesses, brand owners, intellectual property practitioners and applicants seeking rectification of the Register. It reinforces the principle that registration alone does not guarantee perpetual statutory protection and that genuine commercial use remains the cornerstone of trademark rights under Indian law.

Factual and Procedural Background

The dispute centred upon the registered trademark "SHAKTI" in relation to goods falling in Class 30 under the Trade Marks Act, 1999. The petitioner approached the Delhi High Court seeking rectification of the Register of Trade Marks by cancellation of the impugned registration.

According to the petitioner, the trademark had been applied for on 12 March 1996 and was eventually registered on 22 May 2018 in favour of the first respondent under Registration No. 701410. The petitioner asserted that despite obtaining registration, neither the registered proprietor nor the subsequent respondent claiming through the proprietor had genuinely used the trademark in the course of trade. It was alleged that the registration had remained on the Register without satisfying the statutory conditions governing use of registered trademarks.

The petitioner relied upon the provisions contained in Section 47(1)(a) of the Trade Marks Act, 1999, which permits removal of a registered trademark where there has been no bona fide intention to use the mark and where no bona fide use has in fact taken place within the prescribed period. The petitioner also invoked Section 57 of the Act, contending that the continued presence of the trademark on the Register was without sufficient cause and therefore liable to be rectified.

The respondents resisted the petition and attempted to justify the validity of the registration. Among other submissions, reliance was placed upon judicial precedents recognising the concept of honest and concurrent use. It was argued that the registration deserved protection and that objections relating to similarity of marks or likelihood of confusion were not sustainable.

The Court examined the pleadings, documentary evidence, statutory provisions and authorities cited by both sides before deciding whether the impugned registration should continue on the Register.

Dispute Before the Court

The principal controversy before the Court was whether the registered trademark "SHAKTI" could continue to remain on the Register of Trade Marks despite the petitioner's allegation that there had been no genuine commercial use of the mark from the date of its application until its registration and even thereafter.

The Court was required to determine whether the respondents had produced sufficient documentary evidence establishing bona fide use of the trademark in the marketplace and whether the statutory requirements contained in Section 47(1)(a) of the Trade Marks Act had been fulfilled.

Another important issue concerned the applicability of the doctrine of honest and concurrent use. The respondents argued that judicial precedents protecting concurrent users should save the registration, whereas the petitioner maintained that such protection was unavailable because the respondents had failed to establish honest and continuous use through reliable evidence.

The Court also had to consider whether the continued presence of the trademark on the Register amounted to an entry made without sufficient cause so as to justify rectification under Section 57(2) of the Trade Marks Act.

The Court approached the controversy by examining whether the impugned trademark registration satisfied the statutory requirements contained in the Trade Marks Act, 1999. It emphasized that registration of a trademark is not an end in itself. The statutory protection conferred upon a registered proprietor is subject to the obligation that the mark must be genuinely intended to be used and must, in fact, be used in the course of trade. A trademark which remains dormant for years without any commercial exploitation cannot ordinarily continue to enjoy statutory protection merely because it finds a place on the Register.

The Court first examined Section 47(1)(a) of the Trade Marks Act, 1999, which empowers the Court to remove a registered trademark if two essential conditions are established. The first condition is that, at the time of applying for registration, there was no bona fide intention on the part of the applicant to use the trademark in relation to the goods or services for which registration was sought. The second condition is that there has, in fact, been no bona fide use of the trademark up to a period of three months before the filing of application. The provision is intended to ensure that the Register contains only those marks which are genuinely associated with commercial activity and not marks that merely block the entry of others into the market.

The Court observed that the burden shifted to the registered proprietor to establish genuine commercial use once the petitioner produced material questioning the validity of the registration. Mere assertions in pleadings or oral submissions were held to be insufficient. Since trademark rights are commercial rights arising out of trade, the existence of such rights must ordinarily be demonstrated through commercial records such as invoices, sales records, advertisements, promotional material, packaging, tax documents, purchase orders, distribution records or other contemporaneous evidence reflecting actual use of the mark.

Upon examining the evidence produced by the respondents, the Court found a complete absence of reliable documentary material demonstrating that the trademark "SHAKTI" had been used from the date of the application dated 12 March 1996, during the long period preceding registration on 22 May 2018, or even thereafter. The Court recorded a categorical finding that there was no tangible evidence showing continuous or genuine commercial use of the trademark. Consequently, the statutory requirement contained in Section 47(1)(a) stood violated.

The Court next examined Section 57(2) of the Trade Marks Act, 1999, which empowers the High Court to rectify the Register where an entry has been made without sufficient cause or where an entry wrongly remains on the Register. The provision serves an important public function. It ensures that the Register remains accurate and reliable and does not continue to reflect registrations which have ceased to satisfy the statutory requirements. According to the Court, once it had been concluded that the statutory conditions under Section 47 had not been fulfilled, the inevitable consequence was that the registration also became vulnerable under Section 57 because it wrongly remained on the Register despite lacking legal justification.

A substantial part of the arguments advanced by the respondents was founded upon the doctrine of honest and concurrent use. They contended that the registration deserved protection because similar principles had been recognised in earlier judicial precedents. The Court carefully analysed this submission but concluded that the doctrine could not be invoked in the absence of proof of actual use. Honest and concurrent use is an equitable principle intended to protect traders who have independently and honestly adopted similar marks and have genuinely used them over a considerable period. It is not a substitute for evidence of use.

The respondents relied upon the decision of the Supreme Court in London Rubber Co. Ltd. v. Durex Products Incorporated, AIR 1963 SC 1882. In that case, the Supreme Court recognised the concept of honest and concurrent use and upheld registration after considering substantial evidence demonstrating long-standing commercial use by the parties. The Delhi High Court distinguished the decision on facts. It observed that, unlike the factual situation before the Supreme Court in London Rubber, the respondents in the present case had failed to produce any documentary evidence establishing honest and concurrent use of the trademark "SHAKTI". Since the very factual foundation necessary for invoking the doctrine was absent, the ratio of the Supreme Court decision could not assist the respondents.

The respondents also placed reliance upon the judgment of the Supreme Court in Nandhini Deluxe v. Karnataka Cooperative Milk Producers Federation Ltd., (2018) 9 SCC 183. In that decision, the Supreme Court had held that the existence of similar trademarks does not automatically result in deception where the parties operate in different fields of business and deal with different goods or services. The Court had emphasised that the likelihood of confusion must always be examined in the factual context of the competing businesses.

The Delhi High Court held that the reliance upon Nandhini Deluxe was misplaced. It observed that the principle laid down in that case applied where the competing marks related to different goods or distinct commercial fields. In the present case, however, both parties dealt with goods falling in Class 30. Consequently, the possibility of confusion and deception was substantially greater. More importantly, the issue before the Court was not merely one of deceptive similarity but of continued registration despite complete absence of proof of bona fide use. Accordingly, the Court held that the ratio of Nandhini Deluxe had no application to the facts before it.

The Court repeatedly emphasized that registration under the Trade Marks Act creates valuable statutory rights, but those rights are inseparably linked with genuine commercial use. The Act is intended to protect trade, goodwill and consumer confidence rather than to encourage the accumulation of unused registrations. Allowing dormant registrations to remain indefinitely on the Register would unjustifiably restrict honest traders from adopting and registering marks that are genuinely intended for commercial use.

The judgment also reflects the broader policy underlying trademark law. The Register is not merely a record of private rights but a public document relied upon by businesses, consumers and the Trade Marks Registry. Its accuracy and integrity are essential for the effective functioning of the trademark system. Therefore, where the statutory conditions are not satisfied and the registered proprietor cannot establish bona fide use, rectification becomes necessary to preserve the purity of the Register.

After considering the pleadings, documentary evidence, statutory provisions and judicial precedents, the Court concluded that the respondents had failed to discharge the burden of proving genuine commercial use of the trademark. The absence of invoices, sales records, advertisements or any other contemporaneous commercial evidence over an extended period clearly demonstrated that the statutory requirements had not been met. Consequently, the Court held that the trademark registration was liable to be removed under Section 47(1)(a) and that its continued presence on the Register also attracted Section 57(2) of the Trade Marks Act.

Final Decision of the Court

After analysing the pleadings, documentary evidence and the applicable provisions of the Trade Marks Act, 1999, the Court concluded that the respondents had failed to establish bona fide commercial use of the trademark "SHAKTI" from the date of its application on 12 March 1996, up to its registration on 22 May 2018, or even thereafter. The Court found that there was no documentary or tangible evidence demonstrating genuine use of the trademark in the ordinary course of trade. Consequently, the statutory requirements contained in Section 47(1)(a) of the Trade Marks Act stood violated.

The Court further held that once the registration had been shown to have remained on the Register without satisfying the statutory conditions, it also attracted Section 57(2) of the Act because the entry had been made without sufficient cause and wrongly continued on the Register.

Accordingly, the Court directed the Registrar of Trade Marks to cancel and remove Trademark Registration No. 701410 for the mark "SHAKTI" from the Register of Trade Marks within four weeks from the receipt of the order. The rectification petition was disposed of along with the pending applications. No order as to costs was passed.

Point of Law Settled

The judgment reiterates that registration of a trademark is not an absolute or perpetual right. A registered proprietor must be able to establish bona fide intention to use the trademark and genuine commercial use supported by reliable documentary evidence. Mere registration without actual commercial exploitation cannot justify continued statutory protection.

The decision also clarifies that the doctrine of honest and concurrent use cannot be invoked in the absence of convincing evidence showing long-standing, honest and continuous use of the mark. Furthermore, where the statutory requirements under Section 47(1)(a) are violated, the continued presence of the trademark on the Register becomes vulnerable to rectification under Section 57(2) of the Trade Marks Act, 1999.

The judgment reinforces the principle that the Register of Trade Marks must contain only those registrations that represent genuine proprietary rights arising from actual commercial use, thereby preserving the integrity of the trademark registration system.

Title of the Case: Mr. P. C. Duraisamy v. Kewal Krishan Kumar & Anr.

Date of Judgment/Order: 24 June 2026

Case Number: CO(COMM.IPD-TM) 180/2022

Neutral Citation: 2026:DHC:5159

Name of Court: Delhi High Court

Name of Hon'ble Judge: Hon'ble Mr. Justice Tushar Rao Gedela

Written By:Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi

Disclaimer:Images used herein do not reflect the actual images used in the Judgment and are included solely for illustrative purposes. Readers are advised not to treat this article as a substitute for legal advice, as it may contain inadvertent errors in perception, interpretation, or presentation.

Suggested SEO Titles

1. Delhi High Court Cancels SHAKTI Trademark for Non-Use Under the Trade Marks Act, 1999

2. Genuine Trademark Use Mandatory: Delhi High Court Orders Removal of SHAKTI Mark

3. Section 47 Explained: Delhi High Court Removes Trademark for Non-Use

4. Honest and Concurrent Use Rejected: Delhi High Court Rectifies SHAKTI Trademark Registration

5. Delhi High Court Clarifies Law on Trademark Rectification and Non-Use

6. SHAKTI Trademark Removed: Important Delhi High Court Judgment on Trademark Rectification

7. When Can a Registered Trademark Be Cancelled? Delhi High Court Answers

8. Trade Marks Act, 1999: Delhi High Court Strengthens Law Against Dormant Trademark Registrations

9. Documentary Proof of Trademark Use Essential, Rules Delhi High Court

10. Delhi High Court on Sections 47 and 57 of the Trade Marks Act: Comprehensive Analysis

11. Trademark Rectification in India: Delhi High Court Explains Genuine Use Requirement

12. Landmark Delhi High Court Decision on Trademark Non-Use and Register Rectification

Suggested SEO Tags

Trademark Rectification, Trade Marks Act 1999, Section 47 Trade Marks Act, Section 57 Trade Marks Act, Non Use of Trademark, Trademark Cancellation, Trademark Removal, Trademark Registration, Intellectual Property Law, Trademark Litigation, Delhi High Court Trademark Judgment, Honest Concurrent Use, Genuine Use of Trademark, Trademark Register, Rectification Petition, Brand Protection India, Trademark Law India, Trademark Disputes, Class 30 Trademark, IP Litigation, Trademark Evidence, Commercial Use of Trademark, Indian Trademark Law, SHAKTI Trademark Case, 2026 Delhi High Court Judgment, AdvocateAjayAmitabhSuman, IPAdjutor

Headnote of the Judgment

Mr. P. C. Duraisamy v. Kewal Krishan Kumar & Anr., Delhi High Court, CO(COMM.IPD-TM) 180/2022, decided on 24 June 2026. The petitioner sought rectification of the Register of Trade Marks by cancellation of the registered trademark "SHAKTI" on the ground of non-use under Sections 47(1)(a) and 57(2) of the Trade Marks Act, 1999. The Court found that the registered proprietor failed to establish bona fide commercial use of the trademark from the date of application until registration or thereafter. Holding that the statutory conditions for retaining registration had not been satisfied, the Court directed cancellation and removal of the trademark from the Register within four weeks and disposed of the petition without costs.

Info-Graphic Thumbnail Prompt

Create a premium 3D hyper-realistic 8K legal news infographic thumbnail in a 14:9 aspect ratio illustrating a trademark rectification dispute involving the cancellation of a registered trademark for non-use. The central visual should depict a glowing metallic trademark certificate being erased from a futuristic digital Trademark Register, symbolizing cancellation under Sections 47 and 57 of the Trade Marks Act. Include elegant legal scales, a polished courtroom-inspired environment, premium legal dashboards, digital trademark registry screens, evidence folders, commercial invoices fading away, and realistic 3D analytical charts showing "Trademark Rectification, Section 47 (1) (a) of TM Act, No Genuine Use". Use premium red, black, gold and metallic silver colour tones with glowing amber highlights, cinematic lighting, realistic reflections, dramatic shadows and modern intellectual property law aesthetics. Keep text extremely minimal with only: "Trademark Cancelled", "Non-Use", and "Section 47 & 57". Avoid clutter. Do not use the name of any court, lawyer, national flag, Ashoka Emblem, government insignia or judicial symbols identifying any institution. Use realistic visual storytelling through legal graphics rather than text. Use attached image as Image of lawyer in lawyers dress at left bottom corner which should cover 20% of entire image area.

Friday, June 26, 2026

Fraunhofer Gesellschaft Zur Vs. The Controller General of Patents

Comprehensive Analytical Article

Insufficiency of Disclosure in Patent Specification and Rejection of Patent Appeal

Introduction

Factual and Procedural Background

Dispute Before the Court

Thursday, June 25, 2026

SC-Milmet Oftho Industries & Ors. v. Allergan Inc.

Milmet Oftho Industries v. Allergan Inc.: Supreme Court Clarifies Global Reputation, First-in-the-Market Rule and Protection of Pharmaceutical Trademarks

Introduction

Factual and Procedural Background

Dispute Before the Court

Reasoning and Analysis of the Court

Final Decision of the Court

Point of Law Settled

SC-London Rubber Co. Ltd. Vs Durex Products Incorporated

London Rubber Co. Ltd. v. Durex Products Incorporated: Supreme Court Clarifies Honest Concurrent Use in Trademark Registration

Introduction

Factual and Procedural Background

Dispute Before the Court

Reasoning and Analysis of the Court

Final Decision of the Court

Point of Law Settled

Case Details:

Suggested SEO Titles:

Suggested SEO Tags:

Headnote of the Judgment:

Info-graphic Thumbnail Prompt:

SC-Laxmikant V. Patel Vs Chetanbhat Shah

Laxmikant V. Patel v. Chetanbhat Shah & Anr.: Supreme Court Strengthens Protection of Trade Names and Passing Off Rights

Introduction

Factual and Procedural Background

Dispute Before the Court

Reasoning and Analysis of the Court

Final Decision of the Court

Point of Law Settled

Case Details:

Suggested SEO Titles:

Suggested SEO Tags:

Headnote of the Judgment:

Info-graphic Thumbnail Prompt:

Mr. P. C. Duraisamy Vs. Kewal Krishan Kumar & Anr.

Introduction

Factual and Procedural Background

Dispute Before the Court

Blog Archive

Featured Post

WHETHER THE REGISTRAR OF TRADEMARK IS REQUIRED TO BE SUMMONED IN A CIVIL SUIT TRIAL PROCEEDING

My Blog List

My other Blogging Links

About Me

IPR UPDATE BY ADVOCATE AJAY AMITABH SUMAN

Search This Blog

Total Pageviews

Report Abuse